Patent · US Active

Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders

US8722876B2 · kind B2 · utility

0Cited by

4References

10Claims

0Family size

Assignee

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventors

Hermona Soreq · Nesher, IL
Raz Yirmiya · Jerusalem, IL

Key dates

Filing date	May 22, 2013
Grant date	May 13, 2014
Priority date	—
Expiry date	May 22, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

AChE antisense oligonucleotides are used as antiinflammatory agents, such oligonucleotides preferably having the sequence of SEQ ID NO:1 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation of the gastrointestinal tract, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.